(Q49063210)

18 February 2018

title

A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients (English)

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

4 September 2023

1 reference

1 reference

K. R. Norton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6241211

4 September 2023

L. I. Sireling

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6241211

4 September 2023

A. V. Bhat

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6241211

4 September 2023

B. Rao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6241211

4 September 2023

E. S. Paykel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6241211

4 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6241211

4 September 2023

publication date

1 December 1984

1 reference

18 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:016503278490051X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

https://api.elsevier.com/content/article/PII:016503278490051X?httpAccept=text/plain

4 September 2023

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Journal of Affective Disorders

4 September 2023

published in

1 reference

18 February 2018

volume

7

1 reference

18 February 2018

page(s)

297-308

1 reference

18 February 2018

issue

3-4

1 reference

18 February 2018

A double?blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Comparison between zimelidine and desipramine in endogenous depression. A cross-over study

4 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

4 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

4 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

A controlled trial of imipramine in treatment of depressive states.

4 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

4 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Separation and measurement of tricyclic antidepressant in plasma by high-performance liquid chromatography

4 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor

4 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan

4 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Fluvoxamine and chlorimipramine in endogenous depression

4 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Plasma levels and antidepressive effect of imipramine

4 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Development of a Rating Scale for Primary Depressive Illness

4 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Clinical pharmacology of imipramine and related antidepressant compounds

4 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

The Hopkins Symptom Checklist (HSCL)--factors derived from the HSCL-90.

4 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

The efficacy of antidepressant drugs. A review of research (1958-1972).

4 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Duration of antidepressant drug treatment. What is an adequate trial?

4 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Phenelzine and amitriptyline: effects on symptoms of neurotic depression

4 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Fluvoxamine?A new serotonin re-uptake inhibitor: First clinical and psychometric experiences in depressed patients

4 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides

4 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Research diagnostic criteria: rationale and reliability

4 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Mode of action of antidepressant drugs

4 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo

4 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

THE INFLUENCE OF MEDICATION (IMIPRAMINE) AND DOCTOR IN RELIEVING DEPRESSED PSYCHONEUROTIC OUTPATIENTS.

4 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification?

4 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders

4 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0165-0327(84)90051-X

4 September 2023

Identifiers

1 reference

18 February 2018

1 reference

18 February 2018